PS
Pakola Steve
Directeur Médical
OtherM
内部人交易记录
高级管理人员尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Explore the full record of transactions filed by Pakola Steve, Directeur Médical. Director active across 1 company, notably REGENXBIO Inc.. Aggregated, 14 disclosures have been logged. Breakdown: 0 buy · 2 sells. Total volume traded: €71k. Activity tracked since 1 January 2022. The latest transaction was filed on 1 August 2026 (Retenue fiscale). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Pakola Steve
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报14 总计
7,468 股@ US$9.690.011% mcap5.9% 占其流量Common StockSEC:0001700659-26-000016:0
2,161 股@ US$7.860.0022% mcap2.1% 占其流量Common StockSEC:0001700659-26-000014:0
2,161 股@ US$13.640.0039% mcap3.6% 占其流量Common StockSEC:0001700659-26-000014:1
5,124 股@ US$10.354.5% 占其流量Common StockSEC:0001700659-26-000008:0
5,267 股@ US$11.164.9% 占其流量Common StockSEC:0001700659-26-000006:0
65,847 股0Common StockSEC:0001700659-26-000004:0
18,247 股@ US$14.4022.2% 占其流量Common StockSEC:0001700659-26-000003:0
5,263 股@ US$8.076.0% 占其流量Common StockSEC:0001562180-25-003009:0
13,891 股@ US$7.7315.2% 占其流量Common StockSEC:0001562180-25-000190:0
58,386 股0Common StockSEC:0001562180-24-006017:0
12,878 股@ US$22.2538.7% 占其流量Common StockSEC:0001562180-24-002430:0
10,385 股@ US$17.9524.7% 占其流量Common StockSEC:0001562180-24-000252:0
1,837 股@ US$22.685.7% 占其流量Common StockSEC:0001562180-23-000222:0
1,152 股@ US$32.703.3% 占其流量Common StockSEC:0001562180-22-000159:0
About Pakola Steve
PAKOLA STEVE is Directeur Médical and Chief Medical Officer at REGENXBIO Inc. (XNAS). He has 13 filings in total, and across the sampled recent filings, sales amount to EUR 71,455 between 2022-01-04 and 2026-07-06, with the transaction nature listed as tax withholding.